Drreddys Laboratories | Resultado Líquido



Net Income Alterar Data
ANI Pharmaceuticals USD -10276000 13.89M 2024-12
Aurora Cannabis CAD 31.67M 43.71M 2024-12
Bayer EUR -335000000 3.85B 2024-12
Canopy Growth CAD -121896000 6.4M 2024-12
Cipla INR 15.71B 2.68B 2024-12
Corcept Therapeutics USD 30.75M 16.47M 2024-12
Drreddys Laboratories INR 14.13B 1.58B 2024-12
GlaxoSmithKline GBP 414M 472M 2024-12
Hikma Pharmaceutical USD 226M 167M 2024-06
Lonza CHF 329M 85M 2024-06
Novartis USD 2.82B 371M 2024-12
Pacira USD 16.04M 159.51M 2024-12
Prestige Brands USD 61.03M 6.65M 2024-12
Richter Gedeon HUF 37.06B 32.94B 2024-09
Sun Pharmaceuticals INR 29.03B 1.37B 2024-12
Supernus Pharmaceuticals USD 15.33M 23.17M 2024-12
Teva Pharmaceutical Industries USD -217000000 220M 2024-12



Drreddys Laboratories Resultado Líquido - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Apr 2025.